Bioventus Inc (BVS) financials · rev $568.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Bioventus Inc (BVS) rev $568.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $568.1M | $573.3M |
| Cost of Revenue | $179.9M | $185.1M |
| Gross Profit | $388.2M | $388.2M |
| Operating Income | $54.0M | -$12.0M |
| Net Income | $22.7M | -$33.5M |
| EPS (Diluted) | $0.33 | -$0.52 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $683.6M | $728.0M |
| Current Assets | $272.8M | $275.6M |
| Cash & Equivalents | $51.2M | $41.6M |
| Inventory | $82.2M | $92.5M |
| Total Liabilities | $455.1M | $542.4M |
| Current Liabilities | $160.4M | $210.4M |
| Short-term Debt | $15.0M | $27.3M |
| Long-term Debt | $279.0M | $308.3M |
| Total Debt | $294.0M† | $335.6M† |
| Shareholders' Equity | $184.1M | $147.9M |
| Retained Earnings | -$334.9M | -$355.1M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $74.7M | $38.8M |
| CapEx | $2.56M | $1.01M |
| Investing Cash Flow | -$3.25M | $23.0M |
| Financing Cash Flow | -$62.1M | -$54.6M |
| Net Change in Cash | $9.66M | $4.62M |
| Free Cash Flow | $72.1M | $37.8M |
FAQ
What is BVS P/E and revenue?
Bioventus Inc (BVS) rev $568.1M.
What is BVS revenue?
Bioventus Inc last cached revenue is $568.1M (FY2025).
Is BVS profitable?
Bioventus Inc last cached net income is $22.7M (FY2025).
What are BVS total assets?
Bioventus Inc last cached total assets are $683.6M (FY2025).
What is BVS free cash flow?
Bioventus Inc last cached free cash flow is $72.1M (FY2025).
Not investment advice. Cached statements, not a live tape.